Zacks Downgrades Cellcom Israel to Neutral (CEL)
Cellcom Israel (NYSE:CEL) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued to investors on Wednesday, AnalystRatings.Net reports. They currently have a $13.20 target price on the stock. Zacks‘ target price would suggest a potential upside of 13.40% from the stock’s previous close.
Separately, analysts at UBS AG downgraded shares of Cellcom Israel from a “buy” rating to a “neutral” rating in a research note to investors on Wednesday, August 7th.
Cellcom Israel (NYSE:CEL) traded up 1.22% during mid-day trading on Wednesday, hitting $11.64. The stock had a trading volume of 63,484 shares. Cellcom Israel has a 1-year low of $7.05 and a 1-year high of $12.18. The stock has a 50-day moving average of $11.45 and a 200-day moving average of $10.30. The company has a market cap of $1.147 billion and a price-to-earnings ratio of 11.94.
Cellcom Israel (NYSE:CEL) last posted its quarterly earnings results on Monday, August 19th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by $0.08. The company had revenue of $341.60 million for the quarter, compared to the consensus estimate of $414.00 million. On average, analysts predict that Cellcom Israel will post $3.30 earnings per share for the current fiscal year.
Cellcom Israel Ltd. (NYSE:CEL) is a provider of cellular communications services in Israel.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.